Clinical Trial Update: Trial Evaluating Safety, Tolerability and Immune Response of AG-707 [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety, tolerability, and immune response of AG-707 for genital herpes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• AG-707

Snippet

Sponsor: Agenus Inc. | Conditions: Genital Herpes | Phase 1 | Status: COMPLETED